First Data: KSQ Therapeutics to Present First Data from its Proprietary CRISPRomics Discovery Engine

Posters at AACRNCIEORTC and SITC illustrate genomewide in vivo Tcell approach to identify and validate novel therapeutic immunooncology targets KSQ Therapeutics a biotechnology company using CRISPR technology to enable the companys powerful discovery engi...